Para depositar en Docta Complutense, identifícate con tu correo @ucm.es en el SSO institucional. Haz clic en el desplegable de INICIO DE SESIÓN situado en la parte superior derecha de la pantalla. Introduce tu correo electrónico y tu contraseña de la UCM y haz clic en el botón MI CUENTA UCM, no autenticación con contraseña.

CRISPR/Cas9 in Chronic Lymphocytic Leukemia

Thumbnail Image

Download

Download encyclopedia-02-00061.pdf (309.83 KB)

Official URL

https://doi.org/10.3390/encyclopedia2020061

Full text at PDC

Publication date

2022

Authors

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

MPDI
Citations
Google Scholar
Exportar
DC QDC MarcXML RDF MODS METS ORE-ATOM

URI

https://hdl.handle.net/20.500.14352/72090

Citation

Abstract

Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies of Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification of somatic mutations in CLL models.

Research Projects

Organizational Units

Journal Issue

Description

UCM subjects

Oncología, Genética, Bioquímica (Farmacia)

Unesco subjects

3201.01 Oncología, 2409 Genética

Keywords

Collections

Artículos